ARTICLE | Clinical News
Hycamtin topotecan hydrochloride regulatory update
December 7, 2009 8:00 AM UTC
The U.K.'s NICE issued guidance recommending the use of oral Hycamtin topotecan from GlaxoSmithKline only in patients with relapsed small-cell lung cancer (SCLC) for whom re-treatment with the first-l...